6108 — New Ray Medicine International Holding Cashflow Statement
0.000.00%
Last trade - 00:00
- HK$80.25m
- -HK$23.42m
- HK$50.15m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -43.8 | -69.9 | -3.61 | -80.3 | -22.3 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 18 | 62.1 | 5.52 | 54.1 | 4.94 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -40.1 | -33.1 | -69.9 | 15.7 | -37.8 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Payable / Accrued Expenses | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -56.5 | -31.6 | -58.4 | -0.318 | -45.4 |
Capital Expenditures | -1.18 | -0.26 | -0.059 | -8.7 | -0.044 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 3.36 | 7.76 | 131 | 10.3 | -5.97 |
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 2.18 | 7.5 | 131 | 1.62 | -6.01 |
Financing Cash Flow Items | -0.052 | -0.11 | -0.28 | -0.177 | -0.032 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -0.857 | -1.02 | 10.1 | -12.5 | -1.01 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -57.4 | -22.9 | 84.4 | 4.26 | -50.5 |